Literature DB >> 16501607

p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation.

C Leduc1, P Claverie, B Eymin, E Col, S Khochbin, E Brambilla, S Gazzeri.   

Abstract

p14ARF is a tumour suppressor which plays a critical role in p53-dependent or -independent cell growth control. Several studies have recently provided evidence that p14ARF can also interfere either directly or indirectly with some components of the RB signalling pathway to mediate its antiproliferative activity. The aim of this study was to explore the existence of direct relationships between p14ARF and RB proteins. We show that p14ARF promotes the accumulation of a hypoacetylated RB protein, when it is upregulated in a model of stable-inducible clones or physiologically induced following cell exposure to cytotoxic agents. Looking for the mechanisms involved in this process, we demonstrate that the histone acetyl transferase Tip60 directly interacts with RB and stimulates its degradation by the proteasome through acetylation of its C-terminus. Furthermore, and consistent with p14ARF-induced RB accumulation, we provide evidence that p14ARF prevents Tip60-mediated RB acetylation, therefore precluding its proteasomal degradation. Overall, our results identify a novel mechanism by which p14ARF controls the RB pathway to trigger its antiproliferative function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501607     DOI: 10.1038/sj.onc.1209446

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

Review 1.  MYST-family histone acetyltransferases: beyond chromatin.

Authors:  Vasileia Sapountzi; Jacques Côté
Journal:  Cell Mol Life Sci       Date:  2010-12-04       Impact factor: 9.261

2.  Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin.

Authors:  Valerie Edmond; Elodie Moysan; Saadi Khochbin; Patrick Matthias; Christian Brambilla; Elisabeth Brambilla; Sylvie Gazzeri; Beatrice Eymin
Journal:  EMBO J       Date:  2010-12-14       Impact factor: 11.598

3.  Methylation of the retinoblastoma tumor suppressor by SMYD2.

Authors:  Louis A Saddic; Lisandra E West; Aaron Aslanian; John R Yates; Seth M Rubin; Or Gozani; Julien Sage
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

4.  A Code of Mono-phosphorylation Modulates the Function of RB.

Authors:  Ioannis Sanidas; Robert Morris; Katerina A Fella; Purva H Rumde; Myriam Boukhali; Eric C Tai; David T Ting; Michael S Lawrence; Wilhelm Haas; Nicholas J Dyson
Journal:  Mol Cell       Date:  2019-01-30       Impact factor: 17.970

Review 5.  Acetylation and deacetylation--novel factors in muscle wasting.

Authors:  Nima Alamdari; Zaira Aversa; Estibaliz Castillero; Per-Olof Hasselgren
Journal:  Metabolism       Date:  2012-05-22       Impact factor: 8.694

6.  Human DMTF1β antagonizes DMTF1α regulation of the p14(ARF) tumor suppressor and promotes cellular proliferation.

Authors:  Mario P Tschan; Elena A Federzoni; Aladin Haimovici; Christian Britschgi; Bettina A Moser; Jing Jin; Venkateshwar A Reddy; Dennis A Sheeter; Kimberlee M Fischer; Peiqing Sun; Bruce E Torbett
Journal:  Biochim Biophys Acta       Date:  2015-07-15

7.  [Expression of hUTP14a in non-small cell lung cancer].

Authors:  C F Zhang; Y Liu; M Lu; X J DU
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-02-18

8.  Aromatase Acetylation Patterns and Altered Activity in Response to Sirtuin Inhibition.

Authors:  Deborah Molehin; Isabel Castro-Piedras; Monica Sharma; Souad R Sennoune; Daphne Arena; Pulak R Manna; Kevin Pruitt
Journal:  Mol Cancer Res       Date:  2018-06-19       Impact factor: 5.852

Review 9.  RB1, development, and cancer.

Authors:  Meenalakshmi Chinnam; David W Goodrich
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

10.  Potentially functional variants of p14ARF are associated with HPV-positive oropharyngeal cancer patients and survival after definitive chemoradiotherapy.

Authors:  Xicheng Song; Erich M Sturgis; Zhigang Huang; Xiaodong Li; Chao Li; Qingyi Wei; Guojun Li
Journal:  Carcinogenesis       Date:  2013-10-08       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.